Plasma adiponectin: A predictor of coronary heart disease in hemodialysis patients - A Japanese prospective eight-year study

Nephron - Clinical Practice

Volumn 111, Issue 1, 2009, Pages

  Takemoto, Fumi ^a   Katori, Hideyuki ^a   Sawa, Naoki ^a   Hoshino, Junichi ^a   Suwabe, Tatsuya ^a   Nakanishi, Shohei ^a   Arai, Shigeyuki ^b   Fukuda, Seiichi ^b   Kodaka, Kenzo ^b   Shimada, Masaru ^b   Yamazaki, Chihiro ^b   Yokoyama, Keitaro ^a   Nakano, Yasuko ^c   Funahashi, Tohru ^d   Ubara, Yoshifumi ^a   Yamada, Akira ^a   Takaichi, Kenmei ^a   Uchida, Shunya ^b  

^a TORANOMON HOSPITAL   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHOWA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cox's proportional hazard model; Diabetes mellitus; High density lipoprotein cholesterol; Intact parathyroid hormone; Kaplan Meier survival analysis; Sex difference; Waist circumference

Indexed keywords

ADIPONECTIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CAUSE OF DEATH; CHOLESTEROL, HDL; CORONARY DISEASE; CREATININE; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 57049150698     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000178818     Document Type: Article

References (34)

1. Farias MA, McClellan W, Soucie JM, Mitch WE: A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients. Am J Kidney Dis 1994;23:382-388.
2. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606-1615.
3. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-362.
4. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS: Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004;65:2380-2389.
5. Japanese Society for Dialysis Therapy (JSfDT): An Overview of Regular Dialysis Treatment in Japan as of December 31, 2007. Tokyo, JSfDT, 2008.
6. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A: Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003;64:1472-1479.
7. Shik J, Parfrey PS: The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens 2005;14:550-557.
8. Vlagopoulos PT, Sarnak MJ: Traditional and nontraditional cardiovascular risk factors in chronic kidney disease. Med Clin North Am 2005;89:587-611.
9. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33.
10. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K: Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-566.
11. Matsuzawa Y: Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;3:35-42.
12. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with endstage renal disease. J Am Soc Nephrol 2002;13:134-141.
13. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005;16:1091-1098.
14. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
15. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B: Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007;92:571-576.
16. Lawlor DA, Davey Smith G, Ebrahim S, Thompson C, Sattar N: Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005;90:5677-5683.
17. Lindsay RS, Resnick HE, Zhu J, Tun ML, Howard BV, Zhang Y, Yeh J, Best LG: Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 2005;25:e15-e16.
18. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-1737.
19. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB: Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 2005;54:534-539.
20. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006;17:2599-2606.
21. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004;68:975-981.
22. Rathmann W, Haastert B, Herder C, Hauner H, Koenig W, Meisinger C, Holle R, Giani G: Differential association of adiponectin with cardiovascular risk markers in men and women? The KORA Survey 2000. Int J Obes (Lond) 2007;31:770-776.
23. Odamaki M, Furuya R, Kinumura Y, Ikegaya N, Kumagai H: Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients. Nephron Clin Pract 2006;102:c8-c13.
24. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002;51:2734-2741.
25. Schober F, Neumeier M, Weigert J, Wurm S, Wanninger J, Schaffler A, Dada A, Liebisch G, Schmitz G, Aslanidis C, Buechler C: Low-molecular-weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Commun 2007;361:968-973.
26. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002;13:1918-1927.
27. Herder C, Hauner H, Haastert B, Rohrig K, Koenig W, Kolb H, Muller-Scholze S, Thorand B, Holle R, Rathmann W: Hypoadiponectinemia and proinflammatory state: two sides of the same coin? Results from the Cooperative Health Research in the region of Augsburg Survey 4 (KORA S4). Diabetes Care 2006;29:1626-1631.
28. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-617.
29. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218.
30. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12:2131-2138.
31. Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi Y, Fukuhara S, Akizawa T, Saito A, Asano Y, Kurokawa K, Pisoni RL, Port FK: Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan Dialysis Outcomes and Practice Patterns Study. Hemodial Int 2007;11:340-348.
32. Rashid G, Bernheim J, Green J, Benchetrit S: Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 2007;292:F1215-F1218.
33. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH: Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006;114:623-629.
34. Rathmann W, Herder C: Adiponectin and cardiovascular mortality: evidence for 'reverse epidemiology'. Horm Metab Res 2007;39:1-2.